Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Attapulgite is a naturally occurring magnesium aluminium phyllosilicate clay used as an oral antidiarrheal agent. It acts locally in the gastrointestinal tract by adsorbing (binding) water and various substances such as acids and toxins. This reduces stool liquidity and frequency by increasing stool consistency and forming a protective coating on the intestinal lining. Attapulgite is not systemically absorbed or metabolized; it passes through the GI tract unchanged. Historically used in both human and veterinary medicine for symptomatic treatment of acute non-infectious diarrhea; it was formerly an active ingredient in products like Kaopectate before reformulation with bismuth subsalicylate[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Attapulgite.